Atlas Trials

Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma

Clinical trial NCT07030842 · COMPLETED

Trial details

NCT number
NCT07030842
Sponsor
Tongji Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Hepatocellular Carcinoma (HCC)
Start date
2023-08-25
Primary completion
2024-07-30
Enrollment
579

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.